Oncology - European Medical Journal

Continue

Oncology

Filter
EMJ
19 Nov 2015

Update on CheckMate 067, an advanced melanoma clinical trial

James Larkin, MD, PhD gives an update on the clinical trial CheckMate 067, a phase 3 study of Nivolumab or Nivolumab plus Ipilimumab versus Ipilimumab…
EMJ
19 Nov 2015

Physical activity levels and barriers to exercise referral among patients with cancer

Dorothy Yang gives an overview of a study assessing the physical activity levels and barriers to exercise referral among patients with cancer, at the…
EMJ
19 Nov 2015

2015 NCRI Cancer Conference: Featured sessions

Charles Swanton, FRCP, BSc, PhD, of The Francis Crick Institute and Cancer Research UK London Research Institute, London, UK, gives an overview of the…
EMJ
19 Nov 2015

2015 NCRI Cancer Conference: The highlights

Charles Swanton, FRCP, BSc, PhD, of The Francis Crick Institute and Cancer Research UK London Research Institute, London, UK, gives an overview of the…
EMJ
19 Nov 2015

Current status and future prospective of Trial Assigning IndividuaLized Options for Treatment (Rx)

At the European Cancer Congress (ECC) 2015, André Robidoux, MD, FRCSC, of Centre Hospitalier de l’Université de Montréal, Montreal, Canada, discusses…
EMJ
23 Oct 2015

Results and impact of TAILORx: Trial Assigning IndividuaLized Options for Treatment (Rx)

At the European Cancer Congress (ECC) 2015, André Robidoux, MD, FRCSC, of Centre Hospitalier de l’Université de Montréal, Montreal, Canada, discusses…
EMJ
23 Oct 2015

Immunotherapy: Targeting tumour heterogeneity

At the European Cancer Congress (ECC) 2015, Charles Swanton, FRCP, BSc, PhD, of The Francis Crick Institute and Cancer Research UK London Research…
EMJ
15 Oct 2015

New approaches to molecular cancer therapeutics

At the European Cancer Congress (ECC) 2015, Charles Swanton, FRCP, BSc, PhD, of The Francis Crick Institute and Cancer Research UK London Research…